+1 (629)348-3199Perspective - Journal of Parasitic Diseases: Diagnosis and Therapy (2024) Volume 9, Issue 4
Functional Parasitic Gastrointestinal Disorders: Unraveling the Overlooked Link
Article type: Perspective
Home Page URL: https://www.alliedacademies.org/parasitic-diseases-diagnosis-therapy/
Journal short name: J Parasit Dis Diagn Ther
Volume: 9
Issue: 5
PDF No: 199
Citation: Al-Farsi M. Functional Parasitic Gastrointestinal Disorders: Unraveling the Overlooked Link, J Parasit Dis Diagn Ther. 2024; 9(5):199
*Correspondence to: Department of Pathobiology, Sultan Qaboos University, Oman, E-mail: malfarsi.parasite@gmail.com
Received: 27-Sep-2024, Manuscript No. AAPDDT-24-154401; Editor assigned: 01-Oct-2024, PreQC No. AAPDDT-24-154401 (PQ); Reviewed: 15-Oct-2024, QC No. AAPDDT-24-154401; Revised: 22-Oct-2024, Manuscript No. AAPDDT-24-154401 (R); Published: 29-Oct-2024, DOI:10.35841/aapddt-9.5.199
Mohammed Al-Farsi*
Department of Pathobiology, Sultan Qaboos University, Oman
Functional gastrointestinal disorders (FGIDs) are a broad spectrum of chronic conditions, including irritable bowel syndrome (IBS) and functional dyspepsia, characterized by persistent symptoms without identifiable structural or biochemical abnormalities. While diet, stress, and gut microbiota are often highlighted as key factors, an overlooked yet significant contributor to FGIDs is the potential role of parasitic infections. This commentary delves into how parasitic involvement complicates FGID diagnosis and management and emphasizes the need for a more integrative approach in clinical practice.
The Overlooked Parasite Connection
Parasites are often associated with acute gastrointestinal infections, particularly in resource-limited settings. However, growing evidence suggests that chronic, low-level parasitic infections may trigger or exacerbate FGIDs. For instance, protozoa like Blastocystis hominis and Dientamoeba fragilis are frequently detected in individuals with IBS-like symptoms. These parasites may not cause overt tissue damage but can disrupt gut function through mechanisms such as:
- Immune Activation
Chronic parasitic presence can induce low-grade inflammation and alter gut permeability. This can mimic or contribute to the hypersensitivity seen in FGIDs.
- Microbiome Alteration
Parasites can disrupt the delicate balance of gut bacteria, promoting dysbiosis, which is already implicated in FGIDs.
- Neuroimmune Modulation
Certain parasites interact with the enteric nervous system, affecting gut motility and visceral sensitivity, key features in disorders like IBS
Diagnostic Challenges
One of the main challenges is distinguishing functional symptoms from parasitic infections. Routine stool tests often miss low-level or intermittent parasitic infections. Advanced diagnostic tools, such as PCR-based stool analysis, are more sensitive but not commonly used in standard practice. Consequently, many patients undergo treatment for FGIDs without considering a parasitic cause, leading to persistent symptoms and frustration.
Clinical Implications: A Call for Integrative Management
Recognizing the potential role of parasites in FGIDs calls for a shift in both diagnostic and therapeutic approaches:
Enhanced Screening Protocols
In patients with refractory FGID symptoms, especially those with a history of travel or unclear symptom origins, advanced parasitic screening should be considered.
Targeted Therapies
If parasites are detected, antiparasitic treatments could significantly improve symptoms. However, indiscriminate use without diagnosis could harm gut microbiota.
Holistic Treatment Plans
Addressing parasites is not enough. Comprehensive management, including dietary modifications, probiotics, and stress reduction, should complement antiparasitic interventions to restore gut balance.
Conclusion
Functional parasitic gastrointestinal disorders represent a critical intersection between infectious disease and chronic gut dysfunction. As our understanding of the gut ecosystem deepens, acknowledging the role of parasitic infections in FGIDs can open new avenues for more effective diagnosis and treatment. This integrative approach not only holds promise for symptom relief but also highlights the intricate complexity of our gut health. Recognizing and addressing these overlooked parasitic contributors could mark a significant step forward in managing the challenging landscape of FGIDs.
References
Desmonts G, Couvreur J. Congenital toxoplasmosis: a prospective study of 378 pregnancies. N. Engl. J. Med. 1974;290(20):1110-6.
Indexed at, Google Scholar, Cross Ref
Valentini P, Annunziata ML, Angelone DF, et al. Role of spiramycin/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy. Eur J Clin Microbiol Infect Dis. 2009;28(3):297-300.
Indexed at, Google Scholar, Cross Ref
Freeman K, Salt A, Prusa A, et al. Association between congenital toxoplasmosis and parent-reported developmental outcomes, concerns, and impairments, in 3 year old children. BMC pediatrics. 2005;5(1):1-0.
Indexed at, Google Scholar, Cross Ref
Galal L, Hamidovic A, Darde ML, et al. Diversity of Toxoplasma gondii strains at the global level and its determinants. Food and Waterborne Parasitology. 2019; 15:e00052.
Indexed at, Google Scholar, Cross Ref
Gilbert RE, Peckham CS. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen?. J Med Screen. 2002;9(3):135-41.
Indexed at, Google Scholar, Cross Ref
Bornette G, Puijalon S. Response of aquatic plants to abiotic factors: a review. Aquat Sci. 2011;73(1):1-4.
Indexed at, Google Scholar, Cross Ref
Vara Prasad MN, de Oliveira Freitas HM. Metal hyperaccumulation in plants: biodiversity prospecting for phytoremediation technology. Electron J Biotechnol. 2003;6(3):285-321.
Indexed at, Google Scholar, Cross Ref
Raja S, Ramya I. A comprehensive review on Polygonum glabrum. Int J Phytomedic. 2017;8(4):457-67.
Indexed at, Google Scholar, Cross Ref
Pal DK, Nimse SB. Little known uses of common aquatic plant, Hydrilla verticillata (Linn. f.) Royle.
Singh A, Mishra A, Chaudhary R, et al. Role of herbal plants in prevention and treatment of parasitic diseases. J Sci Res. 2020;64:50-8.